{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:17:34Z","timestamp":1765959454638},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1007\/s11883-007-0006-7","type":"journal-article","created":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T14:56:41Z","timestamp":1177513001000},"page":"110-115","source":"Crossref","is-referenced-by-count":61,"title":["The role of hypertriglyceridemia in atherosclerosis"],"prefix":"10.1007","volume":"9","author":[{"given":"Ngoc-Anh","family":"Le","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary F.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,26]]},"reference":[{"key":"6_CR1","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI115499","volume":"88","author":"J.L. Witztum","year":"1991","unstructured":"Witztum JL, Steinberg D: Role of oxidized LDL in atherogenesis. J Clin Invest 1991, 88:1785\u20131792.","journal-title":"J Clin Invest"},{"key":"6_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(98)00173-7","volume":"141","author":"J.W. Heinecke","year":"1998","unstructured":"Heinecke JW: Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized LDL hypothesis. Atherosclerosis 1998, 141:1\u201315.","journal-title":"Atherosclerosis"},{"key":"6_CR3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.20060218","volume":"203","author":"J.W. Heinecke","year":"2006","unstructured":"Heinecke JW: Lipoprotein oxidation in cardiovascular disease: Chief culprit or innocent bystander? J Exp Med 2006, 203:813\u2013816.","journal-title":"J Exp Med"},{"key":"6_CR4","doi-asserted-by":"crossref","first-page":"11019","DOI":"10.1074\/jbc.M512823200","volume":"281","author":"P. Rava","year":"2006","unstructured":"Rava P, Ojakian GK, Shelness GS, Hussain MM: Phospholipid transfer activity of microsomal triacylglycerol transfer protein is sufficient for the assembly and secretion of apolipoprotein B lipoproteins. J Biol Chem 2006, 281:11019\u201311027.","journal-title":"J Biol Chem"},{"key":"6_CR5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/01.ATV.0000151874.81059.ad","volume":"25","author":"H.C. Chen","year":"2004","unstructured":"Chen HC, Farese RV Jr: Inhibition of triglyceride synthesis as a treatment strategy for obesity: Lessons from DGAT1-deficient mice. Arterioscl Thromb Vasc Biol 2004, 25:482\u2013486.","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"6_CR6","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI112713","volume":"78","author":"H.N. Ginsberg","year":"1986","unstructured":"Ginsberg HN, Le NA, Wang-Iverson P, et al.: Apolipoprotein B metabolism in subjects with deficiency of apolipoprotein C-III and A-I: Evidence that apolipoprotein C-III inhibits lipoprotein lipase in vivo. J Clin Invest 1986, 78:1287\u20131295.","journal-title":"J Clin Invest"},{"key":"6_CR7","first-page":"2324","volume":"269","author":"R.C. Kowal","year":"1990","unstructured":"Kowal RC, Herz J, Weisgraber KH, et al.: Opposing effects of apolipoproteins E and C on lipoprotein binding to LDL receptor-related protein. J Biol Chem 1990, 269:2324\u20132335.","journal-title":"J Biol Chem"},{"key":"6_CR8","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.ATV.0000167518.27125.b1","volume":"25","author":"S.O. Olofsson","year":"2005","unstructured":"Olofsson SO: ApoA-V: the regulation of a regulator of plasma triglycerides. Arterioscl Thromb Vasc Biol 2005, 25:1097\u20131099.","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"6_CR9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/07853890500407488","volume":"38","author":"H. Jakel","year":"2006","unstructured":"Jakel H, Nowak M, Helleboid-Chapman A, et al.: Is apoAV a novel regulator of triglyceride-rich lipoproteins? Ann Med 2006, 38:2\u201310.","journal-title":"Ann Med"},{"key":"6_CR10","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1172\/JCI26712","volume":"115","author":"M. Merkel","year":"2005","unstructured":"Merkel M, Heeren J: Give me A5 for lipoprotein hydrolysis. J Clin Invest 2005, 115:2694\u20132696.","journal-title":"J Clin Invest"},{"key":"6_CR11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/01.ATV.0000203519.25116.54","volume":"26","author":"D.C. Chan","year":"2006","unstructured":"Chan DC, Watts GF, Nguyen MN, Barrett PH: Apolipoproteins C-III and A-V as predictors of VLDL triglyceride and apoB-100 kinetics. Arterioscl Thromb Vasc Biol 2006, 26:590\u2013596.","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"6_CR12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-2275(20)37569-6","volume":"37","author":"I.J. Goldberg","year":"1996","unstructured":"Goldberg IJ: Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996, 37:693\u2013707.","journal-title":"J Lipid Res"},{"key":"6_CR13","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.CIR.0000035280.64322.31","volume":"106","author":"H.N. Ginsberg","year":"2002","unstructured":"Ginsberg HN: New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Circulation 2002, 106:2137\u20132142.","journal-title":"Circulation"},{"key":"6_CR14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1001\/archinte.1959.00270010010002","volume":"103","author":"M.J. Albrink","year":"1959","unstructured":"Albrink MJ, Man EB: Serum triglycerides in coronary artery disease. Arch Intern Med 1959, 103:4\u20138.","journal-title":"Arch Intern Med"},{"key":"6_CR15","doi-asserted-by":"crossref","first-page":"3H","DOI":"10.1016\/0002-9149(92)91083-G","volume":"70","author":"W.P. Castelli","year":"1992","unstructured":"Castelli WP: Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 1992, 70(Suppl):3H\u20139H.","journal-title":"Am J Cardiol"},{"key":"6_CR16","doi-asserted-by":"crossref","first-page":"49U","DOI":"10.1016\/S0002-9149(98)00953-9","volume":"82","author":"D.L. Sprecher","year":"1998","unstructured":"Sprecher DL: Triglycerides as a risk factor for coronary artery disease. Am J Cardiol 1998, 82:49U\u201356U.","journal-title":"Am J Cardiol"},{"key":"6_CR17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/01.ATV.18.7.1101","volume":"18","author":"H.T. Westerfeld","year":"1998","unstructured":"Westerfeld HT, Roeters van Lennep JE, Roeters va Lennep HW, et al.: ApoB and CAD in women. A cross-sectional study in women undergoing their first coronary angiography. Arterioscl Thromb Vasc Biol 1998, 18:1101\u20131107.","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"6_CR18","first-page":"213","volume":"3","author":"J.E. Hokansen","year":"1996","unstructured":"Hokansen JE, Austin MA: Plasma triglyceride is a risk factor for cardiovascular disease independent of HDL cholesterol, a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996, 3:213\u2013219.","journal-title":"J Cardiovasc Risk"},{"key":"6_CR19","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/01.ATV.12.11.1336","volume":"12","author":"J.R. Patsch","year":"1992","unstructured":"Patsch JR, Miesenbock O, Hopferwieser T, et al.: Relation of triglyceride metabolism and CAD: studies in the postprandial state. Aretrioscler Thromb Vasc Biol 1992, 12:1336\u20131345.","journal-title":"Aretrioscler Thromb Vasc Biol"},{"key":"6_CR20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/01.ATV.11.3.653","volume":"11","author":"P.H. Groot","year":"1991","unstructured":"Groot PH, van Stiphout WA, Krauss XH, et al.: Postprandial lipoprotein metabolism in normolipidemic with and without coronary disease. Arterioscler Thromb 1991, 11:653\u2013662.","journal-title":"Arterioscler Thromb"},{"key":"6_CR21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.81.2.470","volume":"81","author":"D.H. Blankenhorn","year":"1990","unstructured":"Blankenhorn DH, Alaupovic P, Wickham E, et al.: Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts: lipid and non-lipid factors. Circulation 1990, 81:470\u2013476.","journal-title":"Circulation"},{"key":"6_CR22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.90.1.42","volume":"90","author":"H.N. Hodis","year":"1994","unstructured":"Hodis HN, Mack WJ, Azen SP, et al.: Triglyceride-and cholesterol-rich lipoproteins have a differential effect on mild\/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 1994, 90:42\u201349.","journal-title":"Circulation"},{"key":"6_CR23","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/01.CIR.102.16.1886","volume":"102","author":"F.M. Sacks","year":"2000","unstructured":"Sacks FM, Apaupovic P, Moye LA, et al.: VLDL, apolipoprotein B, C-III, and E, and risk of recurrent coronary events in the CARE trial. Circulation 2000, 102:1886\u20131892.","journal-title":"Circulation"},{"key":"6_CR24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.CIR.85.1.37","volume":"5","author":"V. Manninen","year":"1992","unstructured":"Manninen V, Tenkanen L, Koskinen P, et al.: Joint effects of serum triglyceride and LDLc and HDLc concentrations on coronary heart disease risk in the Helsinki Heart Study: Implication for treatment. Circulation 1992, 5:37\u201345.","journal-title":"Circulation"},{"key":"6_CR25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cca.2005.12.013","volume":"367","author":"K. Nakajima","year":"2006","unstructured":"Nakajima K, Nakano T, Tanaka A: The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects of oxidized LDL and remnant lipoproteins in plasma. Clin Chim Acta 2006, 367:36\u201347.","journal-title":"Clin Chim Acta"},{"key":"6_CR26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0022-2275(20)30125-5","volume":"43","author":"J. McEneny","year":"2002","unstructured":"McEneny J, McMaster C, Tribble ER, Young IS: Rapid isolation of VLDL subfractions: assessment of composition and susceptibility to copper-mediated oxidation. J Lipid Res 2002, 43:824\u2013831.","journal-title":"J Lipid Res"},{"key":"6_CR27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0021-9150(96)06019-4","volume":"129","author":"J. McEneny","year":"1997","unstructured":"McEneny J, Loughrey CM, McNamee PT, et al.: Susceptibility of VLDL to oxidation in patients on regular haemodialysis. Atherosclerosis 1997, 129:215\u2013220.","journal-title":"Atherosclerosis"},{"key":"6_CR28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s001250051333","volume":"43","author":"J. McEneny","year":"2000","unstructured":"McEneny J, O\u2019Kane MJ, Moles KW, et al.: VLDL subfractions in type 2 diabetes mellitus: alterations in composition and susceptibility to oxidation. Diabetologia 2000, 43:483\u2013485.","journal-title":"Diabetologia"},{"key":"6_CR29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/003655102764654330","volume":"62","author":"J. Kaikkonen","year":"2002","unstructured":"Kaikkonen J, Porkkala-Sarataho E, Tuomainen TP, et al.: Exhaustive exercise increases plasma\/serum to oxidation resistance in moderately trained men and women, whereas their VLDL+IDL lipoprotein fraction is more susceptible to oxidation. Scand J Lab Invest 2002, 62:599\u2013608.","journal-title":"Scand J Lab Invest"},{"key":"6_CR30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1079\/BJN2002567","volume":"87","author":"N.S. Nielsen","year":"2002","unstructured":"Nielsen NS, Pedersen A, Sandstrom B, et al.: Different effects of diets rich in olive oil, rapeseed oil and sunflower-seed oil on postprandial lipid and lipoprotein concentrations and on lipoprotein oxidation susceptibility. Br J Nutr 2002, 87:489\u2013499.","journal-title":"Br J Nutr"},{"key":"6_CR31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.ATV.11.3.569","volume":"11","author":"M. Shaikh","year":"1991","unstructured":"Shaikh M, Wootton R, Nordestgaard BG, et al.: Quantitative studies of transfer in vivo of low density, Sf 12-60 and Sf 60-400 lipoproteins between plasma and arterial intima in humans. Arterioscler Thromb 1991, 11:569\u2013577.","journal-title":"Arterioscler Thromb"},{"key":"6_CR32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.ATV.12.1.6","volume":"12","author":"B.G. Nordestgaard","year":"1992","unstructured":"Nordestgaard BG, Tybjaerg-Hansen A: Influx in vivo of low density, intermediate density and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Arterioscler Thromb 1992, 12:6\u201318.","journal-title":"Arterioscler Thromb"},{"key":"6_CR33","first-page":"1768","volume":"14","author":"J.H. Rapp","year":"1994","unstructured":"Rapp JH, Lespine AL, Hamilton RL, et al.: Triglyceride-rich lipoproteins isolated by selected affinity anti-apoB immunoabsorption from human atherosclerotic plaque. Arterioscler Thromb 1994, 14:1768\u20131774.","journal-title":"Arterioscler Thromb"},{"key":"6_CR34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.60.3.473","volume":"60","author":"D.B. Zilversmit","year":"1979","unstructured":"Zilversmit DB: Atherogenesis: a postprandial phenomenon. Circulation 1979, 60:473\u2013485.","journal-title":"Circulation"},{"key":"6_CR35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0167-4889(91)90223-K","volume":"1091","author":"N. Kume","year":"1991","unstructured":"Kume N, Arai H, Kawai C, Kita T: Receptor for modified LDL on human endothelial cells: different recognition for acetylated LDL and oxLDL. Biochim Biophys Acta 1991, 1091:63\u201367.","journal-title":"Biochim Biophys Acta"},{"key":"6_CR36","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.CIR.0000117403.64398.53","volume":"109","author":"H.K. Shin","year":"2004","unstructured":"Shin HK, Kim YK, Kim KY, et al.: Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxLDL receptor-1 activation: prevention by cilostazol. Circulation 2004, 109:1022\u20131028.","journal-title":"Circulation"},{"key":"6_CR37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/01.ATV.0000152632.48937.2d","volume":"25","author":"A. Kawakami","year":"2005","unstructured":"Kawakami A, Tani M, Chiba T, et al.: Pitavastatin inhibits remnant lipoprotein-induced macrophage foam cell formation through apoB-48 receptor-dependent mechanism. Arterioscler Thromb Vasc Biol 2005, 25:424\u2013429.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6_CR38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.RES.0000028454.42385.8B","volume":"91","author":"A. Kawakami","year":"2002","unstructured":"Kawakami A, Tanaka A, Nakajima K, et al.: Atorvastatin attenuates remnant-induced monocyte adhesion to vascular endothelium under flow conditions. Circ Res 2002, 91:263\u2013271.","journal-title":"Circ Res"},{"key":"6_CR39","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.amjcard.2004.12.057","volume":"95","author":"N.A. Le","year":"2005","unstructured":"Le NA, Brown WV, Davis WW, et al.: Comparison of the relation of triglyceride-rich lipoproteins and muscular artery compliance in healthy women versus healthy men. Am J Cardiol 2005, 95:1049\u20131054.","journal-title":"Am J Cardiol"},{"key":"6_CR40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0002-9149(96)00760-6","volume":"79","author":"R.A. Vogel","year":"1997","unstructured":"Vogel RA, Corretti MC, Plotnick GD: Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol 1997, 79:350\u2013354.","journal-title":"Am J Cardiol"},{"key":"6_CR41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00019501-200111000-00006","volume":"12","author":"S.P. Zhao","year":"2001","unstructured":"Zhao SP, Liu L, Gao M, et al.: Impairment of endothelial function after a high-fat meal in patients with CAD. Coron Artery Dis 2001, 12:561\u2013565.","journal-title":"Coron Artery Dis"},{"key":"6_CR42","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0002-9149(02)02847-3","volume":"90","author":"D.A. Plaford","year":"2002","unstructured":"Plaford DA, Watts GF, Best JD, Burke V: Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus. Am J Cardiol 2002, 90:1254\u20131257.","journal-title":"Am J Cardiol"},{"key":"6_CR43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0021-9150(98)00170-1","volume":"141","author":"G.F. Watts","year":"1998","unstructured":"Watts GF, Playford DA: Dyslipoproteinemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis. Atherosclerosis 1998, 141:17\u201330.","journal-title":"Atherosclerosis"},{"key":"6_CR44","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1053\/meta.2000.9518","volume":"49","author":"N.A. Le","year":"2000","unstructured":"Le NA, Li X, Sung K, Brown WV: Evidence for the in vivo generation of oxidatively modified epitopes in patients with documented coronary artery disease. Metabolism 2000, 49:1271\u20131277.","journal-title":"Metabolism"},{"key":"6_CR45","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.amjcard.2003.12.028","volume":"93","author":"Q. Gradek","year":"2004","unstructured":"Gradek Q, Harris M, Yahia N, et al.: Polyunsaturated fatty acids acutely suppress antibodies to malondialdehyde-modified lipoproteins in patients with vascular disease. Am J Cardiol 2004, 93:881\u2013885.","journal-title":"Am J Cardiol"},{"key":"6_CR46","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/diabetes.53.3.701","volume":"53","author":"A. Ceriello","year":"2004","unstructured":"Ceriello A, Quagliaro L, Piconi L, et al.: Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 2004, 53:701\u2013710.","journal-title":"Diabetes"},{"key":"6_CR47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0021-9150(99)00485-2","volume":"152","author":"F.H. Man De","year":"2000","unstructured":"De Man FH, Nieuwland R, van der Laarse, et al.: Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy. Atherosclerosis 2000, 152:407\u2013414.","journal-title":"Atherosclerosis"},{"key":"6_CR48","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00001721-199306000-00006","volume":"4","author":"G. Avellone","year":"1993","unstructured":"Avellone G, di Garbo V, Cordova R, et al.: Fibrinolysis in hypertrigliceridaemic subjects in response to venous occlusion. Blood Coagul Fibrinolysis 1993, 4:429\u2013433.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"6_CR49","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(83)91849-4","volume":"1","author":"H.C. Simpson","year":"1983","unstructured":"Simpson HC, Mann JI, Meade TW, et al.: Hypertriglyceridemia and hypercoagulability. Lancet 1983, 1:786\u2013790.","journal-title":"Lancet"},{"key":"6_CR50","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(86)90111-X","volume":"2","author":"T.W. Meade","year":"1986","unstructured":"Meade TW, Mellows S, Brozovic M, et al.: Haemostatic function and ischaemic heart disease: principal results of the Northwick Park heart Study. Lancet 1986, 2:533\u2013537.","journal-title":"Lancet"},{"key":"6_CR51","doi-asserted-by":"crossref","first-page":"18B","DOI":"10.1016\/S0002-9149(98)00033-2","volume":"81","author":"S.M. Grundy","year":"1998","unstructured":"Grundy SM: Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 1998, 81:18B\u201325B.","journal-title":"Am J Cardiol"},{"key":"6_CR52","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF00400640","volume":"38","author":"P. Knudsen","year":"1995","unstructured":"Knudsen P, Eriksson J, Lahdenpera S, et al.: Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group. Diabetologia 1995, 38:344\u2013350.","journal-title":"Diabetologia"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-007-0006-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-007-0006-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-007-0006-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T21:47:06Z","timestamp":1628804826000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-007-0006-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1007\/s11883-007-0006-7","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}